0001213900-23-018869.txt : 20230309 0001213900-23-018869.hdr.sgml : 20230309 20230309154553 ACCESSION NUMBER: 0001213900-23-018869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230308 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HSU ERIC C CENTRAL INDEX KEY: 0001817867 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 23719548 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0306 4 2023-03-08 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817867 HSU ERIC C C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Sr. VP, Pre-Clinical Res/Dev Employee Stock Option (Expiration) 927.64 2023-03-08 4 H 0 545 0.00 D 2018-03-08 2023-03-08 Common shares 545 8333 D Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00 /s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu 2023-03-09